Inactive Instrument

Highlights Arena Pharmaceuticals

Equities

ARNA

US0400476075

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Longboard Pharmaceuticals, Inc. and Arena Pharmaceuticals, Inc. Executes into Second Amendment to That Certain License Agreement	22-09-19	CI
Pfizer Completes $6.7 Billion Acquisition of Arena Pharmaceuticals	22-03-11	MT
Pfizer Inc. completed the acquisition of Arena Pharmaceuticals, Inc..	22-03-10	CI
Arena Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-23	CI
Arena Pharmaceuticals Extends Q4 Loss, Reports Higher Revenue	22-02-23	MT
Earnings Flash (ARNA) ARENA PHARMACEUTICALS Reports Q4 Revenue $54,000, vs. Street Est of $0.732M	22-02-23	MT
Earnings Flash (ARNA) ARENA PHARMACEUTICALS Reports Q4 Loss $-2.54, vs. Street Est of $-2.23	22-02-23	MT
Arena Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-23	CI
Arena's PT Hiked to $100 by RBC in Line With Pfizer's Proposed Bid; Downgraded to Sector Perform as no Deal Hurdles Seen	21-12-14	MT
EMEA Morning Briefing : Stocks to Rise, Investors -2-	21-12-14	DJ
Social Buzz: Wallstreetbets Stocks Follow Broader Market Lower; Arena Soars on Pfizer Takeover Deal	21-12-13	MT
Pfizer Shares Climb 5% Following Deal to Acquire Arena Pharmaceuticals	21-12-13	DJ
Pfizer Deploying Some of Its Covid Cash in Arena Deal -- Analysis	21-12-13	DJ
Pfizer Eyes Enhanced Immuno-Inflammatory Disease Expertise With $6.7 Billion Arena Pharmaceuticals Takeover	21-12-13	MT
Pfizer bets on Arena's promising bowel disease treatment in $6.7 billion deal	21-12-13	RE
Arena Pharmaceuticals Shares Surge on Takeover by Pfizer	21-12-13	DJ
Pfizer to Acquire Arena Pharmaceuticals in Deal Worth $6.7 Billion	21-12-13	MT
Pfizer to Buy Arena Pharmaceuticals at $6.7 Billion Value	21-12-13	DJ
Pfizer Inc. entered into definitive agreement to acquire Arena Pharmaceuticals, Inc. for $6.3 billion.	21-12-12	CI
Arena Pharmaceuticals Achieves Target Enrollment for Etrasimod Cultivate Study A of the Phase 2/3 CULTIVATE Trial	21-11-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Arena Pharmaceuticals

Equities

ARNA

US0400476075

Highlights

Filters